← Back to Search

Behavioural Intervention

VestAid for Dizziness

N/A
Waitlist Available
Research Sponsored by BlueHalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Snellen visual acuity (corrected) greater than 20/40
* No more than 25dB hearing loss at 500,1000, 2000, and 4000 Hz
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from enrollment weekly for 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

This multi-center randomized trial (MCRT) will investigate the effectiveness of the VestAid application to provide equivalent or faster recovery from dizziness compared to standard-of-care delivery of vestibular rehabilitation exercises.

Who is the study for?
This trial is for individuals experiencing dizziness due to vertigo, vestibular disorders, or brain injuries including concussions. Participants should be seeking treatment for these conditions and have not yet started any vestibular rehabilitation.
What is being tested?
The study is testing the VestAid app's ability to aid in recovery from dizziness against the standard way of doing vestibular rehabilitation exercises. It's a multi-center randomized trial meaning people will be randomly assigned to either use the app or follow standard care.
What are the potential side effects?
Since this trial involves a non-invasive application and standard physical therapy exercises, side effects may include temporary increased dizziness or discomfort during exercise but are generally minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from enrollment weekly for 6 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment weekly for 6 weeks. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dizziness Handicap Inventory (DHI)
Secondary study objectives
Secondary Endpoint

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VestAidExperimental Treatment1 Intervention
Use of VestAid tablet application to aid vestibular rehabilitation
Group II: Standard of Care vestibular rehabilitationActive Control1 Intervention
Use of standard of care vestibular rehabilitation

Find a Location

Who is running the clinical trial?

BlueHaloLead Sponsor
1 Previous Clinical Trials
30 Total Patients Enrolled
University of PittsburghOTHER
1,789 Previous Clinical Trials
16,359,393 Total Patients Enrolled
1 Trials studying Dizziness
~53 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top